• Login
    • Join
  • FOLLOW:
  • Subscribe Free
    • Magazine
    • eNewsletter
    Checkout
    • Magazine
    • News
    • Opinions
    • Top 30
    • Research
    • Supply Chain
    • Device Sectors
    • Directory
    • Events
    • Resources
    • Microsites
    • More
  • Magazine
  • News
  • Opinions
  • Top 30
  • Research
  • Supply Chain
  • Device Sectors
  • Directory
  • Events
  • Resources
  • Microsites
  • Current / Back Issues
    Features
    Editorial
    Digital Edition
    eNewsletter Archive
    Our Team
    Editorial Guidelines
    Reprints
    Subscribe Now
    Advertise Now
    Top Features
    Transporting Treatment: An Examination of Tubing Technologies

    Outward Appearance: Reviewing Surface Treatment Options

    Face to (Virtual) Face: Telemedicine Now and Post-Pandemic

    Voices for Medtech: AdvaMed and MDMA Leaders Share Thoughts

    Digitize Your QMS via an Enterprise Cloud Platform
    OEM News
    Supplier News
    Service / Press Releases
    Online Exclusives
    Press Releases
    People in the News
    Product & Service Releases
    Supplier News
    Medtech Makers
    Technical Features
    International News
    Videos
    Product & Service Releases
    Live From Shows
    Top News
    MICRO Expands with New Facility in Costa Rica

    DiaSorin to Buy Luminex for $1.8B

    Endologix Acquires PQ Bypass

    Algorithm Can Predict Acute Kidney Injury Sooner Than Hospital Systems

    Elixir Medical Begins Study of Metallic Implant for CAD Treatment
    From the Editor
    Blogs
    Guest Opinions
    Top Opinions
    Transporting Treatment: An Examination of Tubing Technologies

    Outward Appearance: Reviewing Surface Treatment Options

    Face to (Virtual) Face: Telemedicine Now and Post-Pandemic

    Voices for Medtech: AdvaMed and MDMA Leaders Share Thoughts

    Digitize Your QMS via an Enterprise Cloud Platform
    Top 30 Medical Device Companies
    Market Data
    White Papers
    Top Research
    Home Is Where the Heart (Valve) Is

    CGM: Digital Health Meets a Very Large Opportunity

    Biomechanical Engineer, Heal Thyself

    Optimizing MIM in Medical Device Manufacturing

    PPE and Diagnostics: Sourcing Domestically and Speeding Time to Market
    3D/Additive Manufacturing
    Contract Manufacturing
    Electronics
    Machining & Laser Processing
    Materials
    Molding
    Packaging & Sterilization
    R&D & Design
    Software & IT
    Testing
    Tubing & Extrusion
    Cardiovascular
    Diagnostics
    Digital Health
    Neurological
    Patient Monitoring
    Surgical
    Orthopedics
    All Companies
    Categories
    Company Capabilities
    Add New Company
    Outsourcing Directory
    Concise Engineering

    Medicoil

    MW Life Sciences

    Qosina Corp.

    PTI Engineered Plastics Inc.
    MPO Summit
    Industry Events
    Webinars
    Live From Show Event
    Industry Associations
    Videos
    Career Central
    eBook
    Slideshows
    Top Resources
    EMS Providers Valued for Product Customization, Medical Certification Expertise

    Three Future Trends and Opportunities in Quality Assurance

    Adopting a Data-Driven Quality Model

    Digital Transformation for Quality and Manufacturing

    Digging into the Cardiac Arrhythmia Monitoring Device Market
    Companies
    News Releases
    Product Releases
    Press Releases
    Product Spec Sheets
    Service Releases
    Case Studies
    White Papers
    Brochures
    Videos
    Outsourcing Directory
    Unicep

    PTI Engineered Plastics Inc.

    Spectrum Plastics Group

    MW Life Sciences

    Forefront Medical Technology
    • Magazine
      • Current/Back Issues
      • Features
      • Editorial
      • Columns
      • Digital Editions
      • Subscribe Now
      • Advertise Now
    • News
    • Directory
      • All Companies
      • ALL CATEGORIES
      • Industry Associations
      • Company Capabilities
      • Add Your Company
    • Supply Chain
      • 3D/Additive Manufacturing
      • Contract Manufacturing
      • Electronics
      • Machining & Laser Processing
      • Materials
      • Molding
      • Packaging & Sterilization
      • R&D & Design
      • Software & IT
      • Testing
      • Tubing & Extrusion
    • Device Sectors
      • Cardiovascular
      • Diagnostics
      • Digital Health
      • Neurological
      • Patient Monitoring
      • Surgical
      • Orthopedics
    • Top 30 Company Report
    • Expert Insights
    • Slideshows
    • Videos
    • Podcasts
    • Resources
    • eBook
    • Infographics
    • Whitepapers
    • Research
      • White Papers
      • Case Studies
      • Product Spec Sheets
      • Market Data
    • MPO Summit
    • Events
      • Industry Events
      • Live From Show Events
      • Webinars
    • Microsite
      • Companies
      • Product Releases
      • Product Spec Sheets
      • Services
      • White Papers / Tech Papers
      • Press Releases
      • Videos
      • Literature / Brochures
      • Case Studies
    • About Us
      • About Us
      • Contact Us
      • Advertise with Us
      • eNewsletter Archive
      • Privacy Policy
      • Terms of Use
    Breaking News

    Medtronic Sees Revenue Losses Due to COVID-19 Pandemic

    The company says it is well positioned for recovery.

    Medtronic Sees Revenue Losses Due to COVID-19 Pandemic
    Given the progression of COVID-19 around the world and the timing of the company’s fiscal quarter, Medtronic’s fourth quarter financial results will reflect an additional month of impact compared to many other companies who operate on a calendar-based fiscal year. Image courtesy of Medtronic.
    Related CONTENT
    • USPTO Issues Patent Covering Hancock Jaffe’s VenoValve
    • Cardiovascular Device Market Expands to Tackle Higher Disease Burden
    • Global Supply Chain Wisdom from Coronavirus-Colored Lenses
    • Diagnosing the IVD Market: An Interview with TEAM Technologies
    • Global Medtech Industry Cross-Border M&A Deals Total $4.5B in Q4 2020
    Globe Newswire04.22.20
    On April 21 Medtronic plc provided an update on its response to the COVID-19 pandemic, the impact on its business, and its strong financial position.
     
    First and foremost, Medtronic has taken a number of steps to help ensure the health and well-being of its more than 90,000 employees and their families around the globe. Second, the company has mobilized its global resources to support patients and physicians in this time of need, including a rapid expansion in the production and distribution of critical products in the fight against COVID-19. Third, Medtronic is partnering with key government agencies and providing direct support to communities around the world.
     
    “I am incredibly proud of the response of our 90,000 global employees. Our resolve to alleviate pain, restore health, and extend life, as outlined in our mission, has never been greater,” said Omar Ishrak, Medtronic chairman and CEO. “I want to recognize and thank our customers, partners, and the healthcare community at large, for their efforts to combat this pandemic. Individually, and collectively, we will persevere.”
     
    Employees
    Medtronic employees continue to work during this pandemic, making critical, lifesaving products to treat both COVID-19 and non-COVID-19 conditions. The company’s manufacturing and distribution facilities are routinely cleaned and sanitized, employees are utilizing personal protective equipment (PPE) and social distancing, including staggered breaks to reduce crowds in common areas, and additional screening and access protocols have been implemented. Field employees who continue to work in clinical settings are provided access to PPE. Importantly, Medtronic has also developed and rolled out to its US employees, and their family members, a free virtual COVID-19 evaluation and monitoring tool through its Care Management Services business.


    Curious how medtech's top companies are responding to the COVID-19 pandemic? Get insights into each company's actions by clicking here.

    Impact on Business
    The impact of COVID-19 on Medtronic’s businesses remains fluid, and the company continues to actively monitor the dynamic situation. Medtronic expects COVID-19 to negatively affect its fiscal fourth quarter financial results, which ends on April 24, 2020. Given the progression of COVID-19 around the world and the timing of the company’s fiscal quarter, Medtronic’s fourth quarter financial results will reflect an additional month of impact compared to many other companies who operate on a calendar-based fiscal year.
     
    Hospital resources have been diverted to fight the pandemic, and many government agencies in conjunction with healthcare systems have made decisions to defer many elective and semi-elective procedures that use the company’s products. In addition, some people are avoiding seeking treatment for non-COVID-19 emergency procedures, resulting in an impact to those emergent product lines. Capital equipment purchases, outside of ventilators and patient monitoring equipment, are also being deferred by hospitals in the current environment.
     
    The following table lists Medtronic’s businesses and therapies that might be considered more urgent, moderately elective, and more elective during the current pandemic:
     
      More Urgent Moderately Elective More Elective
    Cardiac and Vascular Group
    • Pacing
    • Aortic
    • Coronary
    • Cardiac Surgery
    • ICDs/CRT-Ds
    • TAVR/Structural Heart
    • Peripheral
    • AF Solutions
    • EndoVenous
    • Diagnostics
    Minimally Invasive Therapies Group
    • Surgical Innovations: appendectomy, bowel obstruction, trauma
    •  Respiratory and Patient Monitoring
    •  Renal Care
    • Surgical Innovations: CABG, oncology
    • Surgical Innovations: bariatric, hysterectomy, hernia
    • GI
    Restorative Therapies Group
    • Spine: Trauma
    • Neurovascular: ischemic stroke
    • Brain Modulation
    • Neurovascular: hemorrhagic stroke
    • Spine
    • Pain Therapies
    • Pelvic Health
    • ENT
    Diabetes Group
    • Diabetes supplies
     
    • New insulin pump starts

    While the vast majority of Medtronic’s businesses have experienced declines as a result of COVID-19, product lines in the cardiac and vascular, minimally invasive therapies, and diabetes groups are in high demand as a result of COVID-19.
     
    Medtronic also provided insight into the impact of COVID-19 on its business in major geographies, highlighting declines of similar magnitude to those discussed by other medical device companies in the month of February in China and Asia Pacific, in March in Western Europe and the United States, and in forward-looking comments on calendar second quarters of April through June.
     
    In China, which represented approximately 7% of total company revenue pre-COVID-19, the company expects to experience the impact of COVID-19 to its revenue for the entire fiscal fourth quarter. On average, weekly revenue declined approximately 50% year-over-year through the week of March 9. Since that time, the company’s weekly revenue has declined on average approximately 20% to 40% year-over-year, as the market is experiencing a slow recovery.
     
    In Western Europe, which represented approximately 20% of total company revenue pre-COVID-19, the company began to see an impact to revenue from COVID-19 the week of March 23. Over the last few weeks, the company’s weekly revenue has declined approximately 20% to 30% year-over-year on average, excluding any impact from customer bulk purchases.
     
    In the United States, which represented approximately 53% of total company revenue pre-COVID-19, the company began to see an impact to revenue from COVID-19 the week of March 16. Over the last few weeks, the company’s U.S. weekly revenue has declined approximately 60% year-over-year on average, excluding any impact from customer bulk purchases.
     
    In the rest of the world, which represents the remaining 20 percent of total company revenue, Medtronic saw varying degrees of impact, with the last few weeks declining on average approximately 40% to 50% year-over-year.
     
    In addition to the impact to its revenue from procedure volume declines, the company expects an incremental negative impact to revenue from a decline in typical large, end of Medtronic fiscal year customer orders as customers prioritize preservation of cash and reduce their holdings of purchased product inventories, especially in more elective procedure categories, as well as purchases of certain capital equipment.
     
    In general, the company continues to make progress with its pipeline and continues to work with regulatory agencies on timelines that do not appear to be currently affected by the pandemic. Clinical trials that are currently enrolling patients, however, have generally been placed on temporary pause to allow hospital clinical resources to focus on fighting COVID-19.
     
    Financial Position
    Medtronic says it is positioned well for times such as these. The company currently has ample liquidity, with approximately $11 billion in cash and investments as of the most recent quarter, and an undrawn $3.5 billion credit facility. The company has no public debt maturing until March 2021.
     
    Given its strong financial position, Medtronic is continuing to focus on making capital allocation decisions to drive its long-term strategies, including investing in its employees and its pipeline, as well as actively looking for tuck-in acquisition opportunities and paying a strong dividend to its shareholders.
     
    “While the expected short-term impact to our financial results is significant, it is consistent with the impact discussion broadly across the medical device industry,” said Geoff Martha, Medtronic president. “Importantly, we are starting to enter the early stages of a global recovery. As hospitals begin to resume broader treatment of non-COVID-19 patients around the world, we expect our business to begin to recover as well. In addition, given the financial strength of the company, we are executing strategies to come out of this pandemic even stronger, attracting and retaining top talent and increasing and innovating the products and services that we offer physicians, patients, and healthcare systems to win in the evolving marketplace.”
    Related Searches
    • ventilators
    • first
    • diabetes
    • tavr
    Suggested For You
    USPTO Issues Patent Covering Hancock Jaffe’s VenoValve USPTO Issues Patent Covering Hancock Jaffe’s VenoValve
    Cardiovascular Device Market Expands to Tackle Higher Disease Burden Cardiovascular Device Market Expands to Tackle Higher Disease Burden
    Global Supply Chain Wisdom from Coronavirus-Colored Lenses Global Supply Chain Wisdom from Coronavirus-Colored Lenses
    Diagnosing the IVD Market: An Interview with TEAM Technologies Diagnosing the IVD Market: An Interview with TEAM Technologies
    Global Medtech Industry Cross-Border M&A Deals Total $4.5B in Q4 2020 Global Medtech Industry Cross-Border M&A Deals Total $4.5B in Q4 2020
    Medtech Medtech's Cross Border Venture Financing Deals Top $1B in Q4 2020
    GE Healthcare Reveals Vscan Air Wireless, Handheld Ultrasound GE Healthcare Reveals Vscan Air Wireless, Handheld Ultrasound
    Medical Device Cross Border Deal Activity in U.S. Rises in Q4 2020 Medical Device Cross Border Deal Activity in U.S. Rises in Q4 2020
    Cross Border Venture Financing Rose in Final Quarter of 2020 Cross Border Venture Financing Rose in Final Quarter of 2020
    Solid Growth Forecast for Japan Solid Growth Forecast for Japan's MI Neurosurgical Devices Market
    Global Medical Device Venture Financing Deals Total $3.84 Billion in Q4 2020 Global Medical Device Venture Financing Deals Total $3.84 Billion in Q4 2020
    South Korean HIV Testing to Reach Peak Market Value This Year South Korean HIV Testing to Reach Peak Market Value This Year
    Quidel Opens New Manufacturing Facility to Boost COVID-19 Antigen Test Production Quidel Opens New Manufacturing Facility to Boost COVID-19 Antigen Test Production
    4 Trends Driving Medical Manufacturing in 2021 4 Trends Driving Medical Manufacturing in 2021
    Pioneering AI Solutions to Reinforce Healthcare Services Pioneering AI Solutions to Reinforce Healthcare Services

    Related Breaking News

    • MICRO Expands with New Facility in Costa Rica

      MICRO Expands with New Facility in Costa Rica

      Increases its cleanroom assembly capacity to better serve its medical device customers.
      Charles Sternberg, Assistant Editor 04.13.21

    • Diagnostics
      DiaSorin to Buy Luminex for $1.8B

      DiaSorin to Buy Luminex for $1.8B

      Provides access to proven Luminex multiplexing technology and molecular testing solutions.
      Sam Brusco, Associate Editor 04.13.21

    • Cardiovascular
      Endologix Acquires PQ Bypass

      Endologix Acquires PQ Bypass

      Gains proprietary Detour platform for percutaneous femoral-popliteal bypass.
      Sam Brusco, Associate Editor 04.13.21


    • Algorithm Can Predict Acute Kidney Injury Sooner Than Hospital Systems

      Algorithm Can Predict Acute Kidney Injury Sooner Than Hospital Systems

      Dascena's machine learning diagnostic can foretell Stage 2 or Stage 3 AKI up to 48 hours in advance.
      Michael Barbella, Managing Editor 04.13.21

    • Cardiovascular
      Elixir Medical Begins Study of Metallic Implant for CAD Treatment

      Elixir Medical Begins Study of Metallic Implant for CAD Treatment

      Product is designed to adapt to vessel physiology.
      Michael Barbella, Managing Editor 04.13.21

    • Glooko Raises $30 Million in Series D Funding

      Glooko Raises $30 Million in Series D Funding

      Investment follows most successful year in company history.
      Michael Barbella, Managing Editor 04.13.21


    • Diagnostics
      Avantor to Acquire Ritter GmbH and Affiliates for $1B

      Avantor to Acquire Ritter GmbH and Affiliates for $1B

      Expands proprietary offering for diagnostic and drug discovery workflows.
      Sam Brusco, Associate Editor 04.12.21

    • Neurological
      ZOLL Buys Sleep Apnea Device Maker Respicardia

      ZOLL Buys Sleep Apnea Device Maker Respicardia

      Respicardia's remedē system, an implantable neurostimulator, treats central sleep apnea.
      Sam Brusco, Associate Editor 04.12.21

    • Digital Health
      Digital Diabetes Management Market Projected to Reach $54 Billion by 2027

      Digital Diabetes Management Market Projected to Reach $54 Billion by 2027

      Asia Pacific's annual growth rate is expected to skyrocket 19.5 percent, according to data.
      Michael Barbella, Managing Editor 04.12.21


    • EyeYon Medical Raises $25 Million in Series C Funding

      EyeYon Medical Raises $25 Million in Series C Funding

      Latest round brings the company’s valuation to $36 million.
      Michael Barbella, Managing Editor 04.12.21

    • Survey: Remote Patient Monitoring to Match or Surpass In-Patient Within Five Years

      Survey: Remote Patient Monitoring to Match or Surpass In-Patient Within Five Years

      Poll of healthcare professionals affirms that RPM is set to expand rapidly, largely due to COVID-19.
      Michael Barbella, Managing Editor 04.12.21

    • CMS Establishes New Payment for Pelvalon’s Eclipse System

      CMS Establishes New Payment for Pelvalon’s Eclipse System

      Enables women access to a life-changing therapy for loss of bowel control.
      Charles Sternberg, Assistant Editor 04.09.21


    • Chronic Disease | Software & IT
      Varian, Google Cloud Partner to Bring Convenience to Cancer Therapy

      Varian, Google Cloud Partner to Bring Convenience to Cancer Therapy

      Firms will collaborate to build AI tools for radiation oncology organ segmentation using the Google Cloud AI Platform.
      Sam Brusco, Associate Editor 04.09.21

    • Resonetics Leases New Manufacturing Space in Costa Rica

      Resonetics Leases New Manufacturing Space in Costa Rica

      Plans to add second production facility, doubling its capacity.
      Charles Sternberg, Assistant Editor 04.09.21

    • Seisa Medical Acquires ProtoQuick and Peridot

      Seisa Medical Acquires ProtoQuick and Peridot

      Deal gives Seisa a strong presence in the San Francisco Bay area.
      Michael Barbella, Managing Editor 04.09.21


    Trending
    • Endologix Acquires PQ Bypass
    • Survey: Remote Patient Monitoring To Match Or Surpass In-Patient Within Five Years
    • 5 Ways Plastics Revolutionized The Healthcare Industry
    • Portable, Home-Use Device Quickly Measures Inflammation Levels
    • Heart Failure Treatment Using Electrical Microcurrent Shows Promise
    Breaking News
    • MICRO Expands with New Facility in Costa Rica
    • DiaSorin to Buy Luminex for $1.8B
    • Endologix Acquires PQ Bypass
    • Algorithm Can Predict Acute Kidney Injury Sooner Than Hospital Systems
    • Elixir Medical Begins Study of Metallic Implant for CAD Treatment
    View Breaking News >
    CURRENT ISSUE

    April 2021

    • Transporting Treatment: An Examination of Tubing Technologies
    • Face to (Virtual) Face: Telemedicine Now and Post-Pandemic
    • Outward Appearance: Reviewing Surface Treatment Options
    • View More >

    Cookies help us to provide you with an excellent service. By using our website, you declare yourself in agreement with our use of cookies.
    You can obtain detailed information about the use of cookies on our website by clicking on "More information”.

    • About Us
    • Privacy Policy
    • Terms And Conditions
    • Contact Us

    follow us

    Subscribe
    Nutraceuticals World

    Latest Breaking News From Nutraceuticals World

    Review Covers Role of Vitamin K2 in the ‘Calcium Paradox’
    KD Pharma Acquires Rohner AG Manufacturing Assets
    Thorne Healthtech and PreCon Health to Launch Supplements for Pre-, Post-Impact Brain Health
    Coatings World

    Latest Breaking News From Coatings World

    Jebsen & Jessen, Innospec Sign Distribution Agreement
    Sika Expands Production Capacity in Qatar
    Sto Corp. ISO Certifications Extended
    Medical Product Outsourcing

    Latest Breaking News From Medical Product Outsourcing

    MICRO Expands with New Facility in Costa Rica
    DiaSorin to Buy Luminex for $1.8B
    Endologix Acquires PQ Bypass
    Contract Pharma

    Latest Breaking News From Contract Pharma

    Catalent Biologics Completes Madison Expansion
    Lonza Expands PyroTec PRO for Endotoxin Testing
    FDA Accepts Airway Therapeutics’ IND for COVID Treatment
    Beauty Packaging

    Latest Breaking News From Beauty Packaging

    Revieve Launches Skin Coach
    Carlyle Group Acquires Majority Stake in Beautycounter
    The Honest Co. Files for an Initial Public Offering
    Happi

    Latest Breaking News From Happi

    Babor Professional Skin Care Names McCaffrey as Vice President of Sales
    Diamond Chemical Appoints Technical Service Representative
    Carlyle To Acquire Majority Stake in Beautycounter
    Ink World

    Latest Breaking News From Ink World

    Kumon North America Adds Speedmaster XL 106 from Heidelberg
    SE-DA Invests in Kornit Presto S
    Iron Oxide Pigments Market to Register 4.7% CAGR from 2021 to 2028: GVR
    Label & Narrow Web

    Latest Breaking News From Label & Narrow Web

    Enprom helps converter respond to flexible packaging needs
    anytron assists medical device company with labeling
    Dantex debuts new capabilities with white ink opacity
    Nonwovens Industry

    Latest Breaking News From Nonwovens Industry

    Aries Face Masks Meet ASTM Standards
    Tufropes Launches Inherently Antibacterial and Antimicrobial Spunbond
    NXTNano Adding Three Lines
    Orthopedic Design & Technology

    Latest Breaking News From Orthopedic Design & Technology

    GreenBone Ortho Closes 10 Million Euros Series B Funding Round
    SynerFuse, Cirtec Medical Partner to Develop Back Pain Management Device
    New Biosealant Could Stabilize Cartilage, Boost Healing After Injury
    Printed Electronics Now

    Latest Breaking News From Printed Electronics Now

    Virtual ASMC 2021 Spotlights Advanced Semiconductor Manufacturing Excellence
    First Solar Series 6 CuRe has Industry’s Lowest Warranted Degradation Rate
    SEMI: 2020 Global Semiconductor Equipment Sales Surge 19% to Industry Record $71.2 Billion

    Copyright © 2021 Rodman Media. All rights reserved. Use of this constitutes acceptance of our privacy policy The material on this site may not be reproduced, distributed, transmitted, or otherwise used, except with the prior written permission of Rodman Media.

    AD BLOCKER DETECTED

    Our website is made possible by displaying online advertisements to our visitors.
    Please consider supporting us by disabling your ad blocker.


    FREE SUBSCRIPTION Already a subscriber? Login